Brief: Cytomx Therapeutics Inc Cash, Cash Equivalents And Investments Totaled $174.5 Million As Of December 31, 2023
11/03/2024 22:30
March 11 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS INC: CASH, CASH EQUIVALENTS AND
INVESTMENTS
TOTALED $174.5 MILLION AS OF DECEMBER 31, 2023
* CYTOMX THERAPEUTICS INC - QTRLY REVENUE $26.6 MILLION
VERSUS TO
$20.1 MILLION
Source text for Eikon: ID:n0000950170-24-029207
Further company coverage: CTMX.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway